Please use this identifier to cite or link to this item: https://knowledgecommons.lakeheadu.ca/handle/2453/5072
Title: 18F Radiolabeling of epidermal growth factor receptor-tyrosine kinase inhibitor anti-cancer drugs for therapeutic outcome studies
Authors: Kilby, Karissa
Keywords: Epidermal growth factor receptor;Radiochemistry;Positron Emission Tomography (PET)
Issue Date: 2023
Abstract: Epidermal growth factor receptor is a transmembrane protein with tyrosine kinase activity that plays a vital role in the proliferation, differentiation, and survival of normal cells. When mutations in this protein occur, they can cause cancer in which there is currently no cure. Epidermal growth factor receptor-tyroine kinase inhibitor anticancer drugs are available to treat the cancer and allow progression free survival. Not all patients will benefit from this targeted therapy and therefore knowing the mutation status before administering EGFR-TKIs is important. PET imaging can be used to determine level of expression and mutation status instead of repeated invasive biopsies. The problem with these drugs is that resistance is typically seen within 18 months from the start of treatment, therefore this project aims to develop a tracer to be used with positron emission tomography imaging for therapeutic outcome studies to monitor resistance of these drugs in patients. [...]
URI: https://knowledgecommons.lakeheadu.ca/handle/2453/5072
metadata.etd.degree.discipline: Chemistry
metadata.etd.degree.name: Master of Science
metadata.etd.degree.level: Master
metadata.dc.contributor.advisor: Campbell, Michael
metadata.dc.contributor.committeemember: Floriano, Wely
Hou, Jinqiang
Gottardo, Christine
Appears in Collections:Electronic Theses and Dissertations from 2009

Files in This Item:
File Description SizeFormat 
KilbyK2023m-1a.pdf5.08 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.